Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Jul 22, 2025 | Curreen Capital | 14.1% | 8.7% | AAP, CACC, ENR GR, FTDR, FTRE, GETB LN, HAVAS NA, TRUEB SS, VFC | contrarian, mispricing, Patience, Return on Capital, Turnarounds | The letter describes an ugly duckling strategy focused on temporarily impaired businesses with durable long-term economics. Management argues that operational setbacks and industry slowdowns create mispriced opportunities for patient investors. The outlook is optimistic as normalized earnings and returns on capital re-emerge. | VFC ENR GR GETB LN FTDR FTRE CACC AAP |
View |
| 2025 Q1 | Apr 24, 2025 | Prosper Stars & Stripes | -9.7% | -9.7% | AMSC, COLD, FLYW, FTRE, HELE, KRMN, MTLS, NSIT, PYCR, RGEN, SARO, TLN, TRS, XMTR | - | View | ||
| 2023 Q3 | Oct 31, 2023 | Starboard Value | 0.0% | 0.0% | CRM, FTRE, GDDY, SPLK, VERT, WIX | - | View | ||
| 2023 Q3 | Oct 30, 2023 | Penn Davis McFarland | - | - | FTRE, LLYVK, MSFT | - | View | ||
| 2025 Q3 | Oct 24, 2025 | Curreen Capital | 9.0% | 18.5% | AAP, CACC, EHAB, ENR GR, FTDR, FTRE, GETB LN, KTB, PLX FP, THNC CN, VFC | cash flow, Health Care, small caps, turnaround, value | The fund gained 9%, focusing on smaller turnaround and value situations like Kontoor Brands and Fortrea. Managers emphasize disciplined capital allocation, strong cash generation, and improving healthcare fundamentals despite regulatory headwinds. The portfolio reflects bottom-up conviction in underappreciated growth and restructuring stories. | FTRE THNC CN GETB GB KTB ENH FTRE THNC CN GETB GB KTB ENH |
View |
| 2025 Q4 | Jan 29, 2026 | Curreen Capital | 10.5% | 31.0% | AAP, DND.TO, ENR.DE, FTDR, FTRE, GETB.L, TRUE-B.ST, VFC | energy, healthcare, small caps, spinoffs, Turnarounds, value | Curreen Capital has been particularly successful with spinoff investments since launch, with 2025's three biggest winners all being spinoffs. The manager views ugly duckling spinoffs as the best investment opportunities when they combine good businesses, capable management, and attractive pricing. The fund focuses on 'ugly ducklings' - good businesses run by capable managers bought at attractive prices with upside-to-downside ratios of at least 5:1. They target companies earning above 20% after-tax returns on capital over time. Siemens Energy benefited from the end of decade-long stagnation in global electricity demand, driven by deferred infrastructure maintenance, continued electrification, and rapid rise of AI spurring a new demand cycle. | AAP FTRE FTDR GETB LN ENG GR VFC |
View |
| 2025 Q4 | Jan 27, 2026 | Voya MI Dynamic Small Cap Fund | 0.0% | 0.0% | BE, FLS, FOLD, FTRE, GEO, HPP | AI, Biotechnology, healthcare, industrials, real estate, small caps, technology | AI remained a dominant theme with strong headlines around innovation and elevated capital investment by major technology firms. Increased spending on AI infrastructure and adoption trends reinforced optimism about its role as a key driver of future growth. AI-driven innovation is supporting the broadening of market leadership beyond mega-cap growth. The fund focuses on US Small Cap Core equity strategy with broader market participation persisting, where small caps and cyclicals contributed to market performance. Market leadership is widening beyond mega-cap growth, creating opportunities in the small cap space. The fund held positions in commercial stage biotechnology companies focused on rare disease therapies. Amicus Therapeutics delivered strong results as product sales rose both domestically and abroad, while Fortrea Holdings provided operational services to biopharmaceutical companies with strong net bookings. | FTRE FOLD FLS GEO HPP BE |
View |
| 2024 Q3 | Sep 30, 2024 | Diamond Hill Small-Mid Cap Strategy | 8.4% | 9.2% | ASH, BBWI, COOP, CUBE, FTRE, HII, LANC, LOB, NVR, RRX | - | View | ||
| 2024 Q2 | Jul 26, 2024 | Diamond Hill Small-Mid Cap Strategy | 8.4% | 9.2% | ALGT, COOP, FTRE, GDDY, LH, MGY, RRR, SNV, UDR, VRSN, WCC | - | View | ||
| 2023 Q3 | Apr 10, 2023 | Vltava Fund | 0.0% | 0.0% | ELV, FTRE, HUM, WTW | - | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | Fund Letters | Christian Ryther | Fortrea Holdings Inc. | Health Care | Life Sciences Services | Bull | NASDAQ | Clinicaltrials, Cro, healthcare, turnaround, valuation | View Pitch |
| Jan 29, 2026 | Fund Letters | Sanne de Boer | Fortrea Holdings Inc. | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | Bookings, Cro, healthcare, lifesciences, recovery | View Pitch |
| Dec 5, 2025 | Fund Letters | Christian Ryther | Fortrea Holdings Inc. | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | backlog, Clinical, Cro, spinoff, turnaround, valuation | View Pitch |
| Nov 29, 2025 | Fund Letters | Christian Ryther | Fortrea Holdings Inc. | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | Cro, life sciences, Margin recovery, restructuring, spin-off, turnaround | View Pitch |
| Nov 29, 2025 | Fund Letters | Christian Ryther | Fortrea Holdings Inc. | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | Cro, life sciences, Margin recovery, restructuring, spin-off, turnaround | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||